Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial type II topoisomerase refers to a group of essential enzymes, primarily DNA gyrase and topoisomerase IV, that regulate the topological state of the bacterial genome during DNA replication, transcription, and recombination [1, 5, 11]. DNA gyrase is unique in its ability to introduce negative supercoils into DNA, a process vital for chromosome compaction and the relief of torsional stress [5, 15]. Topoisomerase IV is primarily responsible for the decatenation of interlinked daughter chromosomes, allowing for successful cell division [5, 13]. These enzymes are heterotetrameric complexes consisting of two distinct subunits (GyrA/GyrB or ParC/ParE) and are the primary targets of fluoroquinolone antibiotics [4, 11, 13]. Fluoroquinolones function as topoisomerase poisons by trapping the enzyme in a covalent complex with DNA, leading to the accumulation of lethal double-strand breaks [2, 6, 15]. Other inhibitors, such as aminocoumarins, target the ATPase domain to block the energy-dependent catalytic cycle [1, 11]. Given the rise of antibiotic resistance, these enzymes remain critical targets for the development of novel antibacterial agents with distinct mechanisms of action [3, 13].
Inhibition of DNA ligation and stabilization of the enzyme-DNA cleavage complex (topoisomerase poisons); competitive inhibition of ATPase activity; inhibition of DNA supercoiling and decatenation.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial type II topoisomerase (Topo II (Bacterial)).